Structure via PubChem · Public domain (PubChem)
AUT-00063
Sign in to saveAlso known as AUT00063
AUT00063 (also called AUT-00063) is an investigational small-molecule compound developed by Autifony Therapeutics for hearing loss and tinnitus.
Chemical data
- Formula
- C20H21N3O4
- Molecular weight
- 367.4 g/mol
- IUPAC name
- 5,5-dimethyl-3-[6-[(4-methyl-3,4-dihydro-2H-chromen-5-yl)oxy]-3-pyridinyl]imidazolidine-2,4-dione
- SMILES
- CC1CCOC2=C1C(=CC=C2)OC3=NC=C(C=C3)N4C(=O)C(NC4=O)(C)C
- InChIKey
- FEABXCREHFVJCI-UHFFFAOYSA-N
- XLogP
- 2.8
- Polar surface area
- 80.8 Ų
- H-bond donors
- 1
- H-bond acceptors
- 5
- Formal charge
- 0
via PubChem
Wikidata facts
- Subclass of
- small molecule
- Mass
- 367.4
- Has use
- medication
Show 4 more facts
- route of administration
- oral administration
- medical condition treated
- hearing loss
- chemical formula
- C₂₀H₂₁N₃O₄
- canonical SMILES
- CC1CCOc2cccc(Oc3ccc(N4C(=O)NC(C)(C)C4=O)cn3)c21
via Wikidata · CC0
~2 min read
Encyclopedic overview
6 sectionsContents
- Background and development
- Clinical trials
- Tinnitus (QUIET-1)
- Mechanism of action
- See also
- References
AUT00063 (also called AUT-00063) is an investigational small-molecule compound developed by Autifony Therapeutics for hearing loss and tinnitus.
== Background and development ==
Excerpted from Wikipedia’s “AUT-00063” article, available under the CC BY-SA 4.0 licence.